When and how often should PET scans be performed in the management of cervical cancer?

Expert Rev Anticancer Ther. 2010 Jul;10(7):983-6. doi: 10.1586/era.10.78.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Biomarkers, Tumor / blood
  • Cost-Benefit Analysis
  • Female
  • Fluorine Radioisotopes
  • Fluorodeoxyglucose F18
  • Humans
  • Lymphatic Metastasis / diagnostic imaging*
  • Magnetic Resonance Imaging
  • Neoadjuvant Therapy
  • Neoplasm Staging / methods
  • Positron-Emission Tomography* / economics
  • Radiopharmaceuticals
  • Salvage Therapy
  • Time Factors
  • Tomography, X-Ray Computed
  • Uterine Cervical Neoplasms / blood
  • Uterine Cervical Neoplasms / diagnostic imaging*
  • Uterine Cervical Neoplasms / drug therapy
  • Uterine Cervical Neoplasms / pathology

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor
  • Fluorine Radioisotopes
  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18